C Wu Joseph相关文献与解析，生知库 | 链接生命科学的每一步

Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies

解读新冠肺炎长期相关心血管功能障碍：机制、模型和新方法

期刊:Journal of Molecular and Cellular Cardiology

影响因子:4.7

doi:10.1016/j.yjmcc.2025.09.008

Thomas, Dilip; Yang, Phillip C; Wu, Joseph C; Sayed, Nazish

Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program

根据基线改良 Mayo 评分分层评估 Etrasimod 对中重度活动性溃疡性结肠炎患者的疗效和安全性：一项来自 3 期 ELEVATE UC 临床项目的后分析

期刊:Inflammatory Bowel Diseases

影响因子:4.3

doi:10.1093/ibd/izaf036

Sands, Bruce E; Dubinsky, Marla C; Kotze, Paulo G; Vermeire, Séverine; Panaccione, Remo; Long, Millie D; Woolcott, John C; Wu, Joseph; McDonnell, Aoibhinn; Goetsch, Martina; Bananis, Eustratios; Yarur, Andres J

Generation of two induced pluripotent stem cell lines from patients with Li-Fraumeni Syndrome carrying TP53 mutation.

从患有 TP53 突变的 Li-Fraumeni 综合征患者中生成两种诱导多能干细胞系

期刊:Stem Cell Research

影响因子:0.7

doi:10.1016/j.scr.2024.103527

Sun Junyi, Ren Lu, Canel Rivero Gabriela, Xu Lingyun, Ladabaum Uri, C Wu Joseph

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo

接受托法替尼、阿达木单抗或安慰剂治疗的银屑病关节炎患者的临床和患者报告结局的起效时间

期刊:Arthritis Research & Therapy

影响因子:4.6

doi:10.1186/s13075-022-02721-0

Gladman, Dafna D; Coates, Laura C; Wu, Joseph; Fallon, Lara; Bacci, Elizabeth D; Cappelleri, Joseph C; Bushmakin, Andrew G; Helliwell, Philip S

Reconstructing the heart using iPSCs: Engineering strategies and applications

利用诱导多能干细胞重建心脏：工程策略和应用

期刊:Journal of Molecular and Cellular Cardiology

影响因子:4.7

doi:10.1016/j.yjmcc.2021.04.006

Cho, Sangkyun; Lee, Chelsea; Skylar-Scott, Mark A; Heilshorn, Sarah C; Wu, Joseph C

Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease

简明综述：干细胞疗法治疗心脏病临床前和临床研究中细胞剂量和给药途径的回顾与展望

期刊:Stem Cells Translational Medicine

影响因子:4.9

doi:10.5966/sctm.2015-0101

Golpanian, Samuel; Schulman, Ivonne H; Ebert, Ray F; Heldman, Alan W; DiFede, Darcy L; Yang, Phillip C; Wu, Joseph C; Bolli, Roberto; Perin, Emerson C; Moyé, Lem; Simari, Robert D; Wolf, Ariel; Hare, Joshua M

Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation

共刺激-粘附阻断疗法在预防分化的人类胚胎干细胞移植后的排斥反应方面优于环孢素A和泼尼松免疫抑制疗法。

期刊:Stem Cells

影响因子:3.6

doi:10.1002/stem.1501

Huber, Bruno C; Ransohoff, Julia D; Ransohoff, Katherine J; Riegler, Johannes; Ebert, Antje; Kodo, Kazuki; Gong, Yongquan; Sanchez-Freire, Veronica; Dey, Devaveena; Kooreman, Nigel G; Diecke, Sebastian; Zhang, Wendy Y; Odegaard, Justin; Hu, Shijun; Gold, Joseph D; Robbins, Robert C; Wu, Joseph C

Enhanced Aβ(1-40) production in endothelial cells stimulated with fibrillar Aβ(1-42)

纤维状 Aβ(1-42) 刺激内皮细胞产生更多 Aβ(1-40)

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0058194

Jayakumar Rajadas, Wenchao Sun, Hai Li, Mohammed Inayathullah, Damiano Cereghetti, Aaron Tan, Valeria de Mello Coelho, Francis J Chrest, John W Kusiak, Wanli Wei Smith, Dennis Taub, Joseph C Wu, Joseph M Rifkind

Noninvasive imaging of hypoxia-inducible factor-1α gene therapy for myocardial ischemia

无创成像技术用于检测缺氧诱导因子-1α基因疗法治疗心肌缺血

期刊:Human Gene Therapy Methods

影响因子:

doi:10.1089/hgtb.2013.028

Chen, Ian Y; Gheysens, Olivier; Li, Zongjin; Rasooly, Julia A; Wang, Qian; Paulmurugan, Ramasamy; Rosenberg, Jarrett; Rodriguez-Porcel, Martin; Willmann, Juergen K; Wang, David S; Contag, Christopher H; Robbins, Robert C; Wu, Joseph C; Gambhir, Sanjiv S

心血管

发表日期：2013

文献求助收藏

Low Incidence of Macular Edema and Other Ocular Events in the Etrasimod Development Program

Etrasimod 开发项目中黄斑水肿和其他眼部事件发生率低

Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies

解读新冠肺炎长期相关心血管功能障碍：机制、模型和新方法

Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program

根据基线改良 Mayo 评分分层评估 Etrasimod 对中重度活动性溃疡性结肠炎患者的疗效和安全性：一项来自 3 期 ELEVATE UC 临床项目的后分析

Generation of two induced pluripotent stem cell lines from patients with Li-Fraumeni Syndrome carrying TP53 mutation.

从患有 TP53 突变的 Li-Fraumeni 综合征患者中生成两种诱导多能干细胞系

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo

接受托法替尼、阿达木单抗或安慰剂治疗的银屑病关节炎患者的临床和患者报告结局的起效时间

Reconstructing the heart using iPSCs: Engineering strategies and applications

利用诱导多能干细胞重建心脏：工程策略和应用

Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease

简明综述：干细胞疗法治疗心脏病临床前和临床研究中细胞剂量和给药途径的回顾与展望

Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation

共刺激-粘附阻断疗法在预防分化的人类胚胎干细胞移植后的排斥反应方面优于环孢素A和泼尼松免疫抑制疗法。

Enhanced Aβ(1-40) production in endothelial cells stimulated with fibrillar Aβ(1-42)

纤维状 Aβ(1-42) 刺激内皮细胞产生更多 Aβ(1-40)

Noninvasive imaging of hypoxia-inducible factor-1α gene therapy for myocardial ischemia

无创成像技术用于检测缺氧诱导因子-1α基因疗法治疗心肌缺血